{"name":"Paul S. Aisen","slug":"paul-s-aisen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9PaGhfcmlvVUxzdzFkVlJVRm85eC0zTFlvQkZuelI2a3N1RmVuZWpKTmw2cWF2Ui1UXzFzOUVRckQ1TlhCUVR3ZGVUbVFDMFhZaXBiRnJ1VElJN0ZsMi1GWjdlQjBTZWIzelRaX0dFYkpXSXA5YUliM0NZaFY?oc=5","date":"2024-09-22","type":"regulatory","source":"Wiley","summary":"Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagement - Wiley","headline":"Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating c","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9GNEJnbUdIOFBCOWd4b0U1bFdMdklqbmdadUxNLW1TRWZRdkJZWlpYWXZrZUo4V0RENHlJd3Q1c0k1TVM1MUM2QnpqUEt2cndJYU45VEV1YTAtNWRJeHJPTDk5N21kVEV2?oc=5","date":"2023-01-10","type":"trial","source":"Wiley Online Library","summary":"Natural cubic splines for the analysis of Alzheimer's clinical trials - Donohue - 2023 - Pharmaceutical Statistics - Wiley Online Library","headline":"Natural cubic splines for the analysis of Alzheimer's clinical trials - Donohue - 2023 - Pharmaceutical Statistics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JTEUyVVdhdWdFelNqUVRJZG82clVwblhfWGhjU2g0UVpIZDhMRkdjZERqUjhXN2NtbFgxZmhZcUFPeU5BaHE4a0JaMll0YVQ4Z0o4UW02SUpoQlNoYk1J?oc=5","date":"2022-04-04","type":"trial","source":"nature.com","summary":"Early-stage Alzheimer disease: getting trial-ready - nature.com","headline":"Early-stage Alzheimer disease: getting trial-ready","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNNXI3R21SMjM4MlY2T1RJdVUxRHAyUGN5UnZfa2FVRm5sVEQtVnJMcUU0VlJxSUl6bTQ2YzNUOE9NOWRWcEJpVnBkeG5vN2tfMUg2UDJrMlBMSjF6bnhUR0Q2alFBMkRTdkxmcnBJTFhKRHUtYkROcGhTYlhBNmdlN0F1akNkaEdXZ21PdmszMEg1MktXUVhFT0d2eFJGUlF6UGVVMkNR0gGrAUFVX3lxTE1xeVlDUjVKLUJ0T2tCb0laaTBsWEZMM2pFRW5rQzE0a2VuUk0tM21RMVFFeUh4M3l2aUY3WU9NVDhUVGxURHJCMUxUZTExZERhZ251dU5hOEV4TWhoT2U3UFZqZ0F1blVkVS1yQ01FVVdwbGtweGh2OGdaLUhrbGxvWHBzeEFmUWQxQ3hOQmlKWXlZQVpPM1VQZ1ZKWUh5MzJWTmpOM3FxelRSRQ?oc=5","date":"2021-06-12","type":"pipeline","source":"CNBC","summary":"Biogen Alzheimer’s drug and the battle over dementia treatment of the future - CNBC","headline":"Biogen Alzheimer’s drug and the battle over dementia treatment of the future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFA4cExYeXd4SmJfZjdPSlBuTWFrQXFFcEQ0UnczRUxPTXJzWjFOcFlZcWhvcFBnOFktM2k1VEpqdG0waFY4c3J1bzByaDNCOFZ4T2Y1dWFxSTF4eWN4YmJ5NkVrOWVUVGpWSGN2NFVYdC0xem5mX1ROYl9zbmlfNEk?oc=5","date":"2020-02-12","type":"trial","source":"Keck School of Medicine of USC","summary":"USC’s new Alzheimer’s study featured in TV report - Keck School of Medicine of USC","headline":"USC’s new Alzheimer’s study featured in TV report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOczdLVXNNVmNfLWduS2plcTRRbktOSGNra0J2VmxJWWgzUWVmUlNRNmJoOWxlQUx2MWtiX2ZXWUVBOEtiZkJjY09EamdQRzhtTXowaUkxZWJvMTVMcUdfS3lnQTU3ZjlWMHB5UWxSdGhJcFhCdHBRVGltdExRVDlJN1JPUUlTMVVz?oc=5","date":"2017-07-17","type":"pipeline","source":"Los Angeles Times","summary":"An overdose, a young companion, drug-fueled parties: The secret life of a USC med school dean - Los Angeles Times","headline":"An overdose, a young companion, drug-fueled parties: The secret life of a USC med school dean","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}